Search

everythinglearnresearchcommunity

for

Search:↓

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

PlncRNA-1 helps hair follicle stem cells grow and develop by controlling a specific cell signaling pathway.

AI can help diagnose Follicular Lymphoma by accurately identifying specific cell types.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Early balding men may have insulin resistance, but lifestyle changes can help.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

4-O-Methylhonokiol from Magnolia shows promise for hair growth, cancer, diabetes, and more, but needs better absorption.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Vitex negundo has potential health benefits, including anti-inflammatory and anti-cancer effects.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.